Immunocore Holdings Plc [IMCR]

Source: 

Company Overview

Immunocore Holdings Plc is a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, infectious and autoimmune.